Nika Pharmaceuticals, Inc (NIKA) Invested Capital (2021 - 2023)

Nika Pharmaceuticals (NIKA) has 3 years of Invested Capital data on file, last reported at $18180.0 in Q4 2023.

• Quarterly Invested Capital changed 0.0% year-over-year to $18180.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $221015.0 (up 708.63% YoY) and the FY2023 annual result came in at $18180.0, changed 0.0% from the prior year.
• Invested Capital eased to $18180.0 in Q4 2023, from $85745.0 in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $85745.0 in Q3 2023 to a low of $2972.0 in Q2 2022.
• A 3-year average of $32358.1 and a median of $18180.0 in 2022 frame the typical range for Invested Capital.
• The widest YoY moves for Invested Capital: up 2448.62% in 2023, down 0.0% in 2023.
• Tracing NIKA's Invested Capital over 3 years: stood at $10518.0 in 2021, then surged by 72.85% to $18180.0 in 2022, then changed by 0.0% to $18180.0 in 2023.
• The last three Invested Capital figures came in at $18180.0 (Q4 2023), $85745.0 (Q3 2023), and $75745.0 (Q2 2023), per Business Quant data.